Bronte, G.; Cosi, D.M.; Magri, C.; Frassoldati, A.; Crinò, L.; Calabrò, L.
Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach? Int. J. Mol. Sci. 2023, 24, 12622.
https://doi.org/10.3390/ijms241612622
AMA Style
Bronte G, Cosi DM, Magri C, Frassoldati A, Crinò L, Calabrò L.
Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach? International Journal of Molecular Sciences. 2023; 24(16):12622.
https://doi.org/10.3390/ijms241612622
Chicago/Turabian Style
Bronte, Giuseppe, Donato Michele Cosi, Chiara Magri, Antonio Frassoldati, Lucio Crinò, and Luana Calabrò.
2023. "Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?" International Journal of Molecular Sciences 24, no. 16: 12622.
https://doi.org/10.3390/ijms241612622
APA Style
Bronte, G., Cosi, D. M., Magri, C., Frassoldati, A., Crinò, L., & Calabrò, L.
(2023). Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach? International Journal of Molecular Sciences, 24(16), 12622.
https://doi.org/10.3390/ijms241612622